In the US, Rituxan (rituximab systemic) is a member of the following drug classes: antirheumatics, CD20 monoclonal antibodies and is used to treat Bullous Pemphigoid, Chronic Lymphocytic Leukemia, Evan's Syndrome, Follicular Lymphoma, Idiopathic Thrombocytopenic Purpura, Microscopic polyangiitis, Non-Hodgkin's Lymphoma, Pemphigoid, Pemphigus, Rheumatoid Arthritis and Wegener's Granulomatosus.
US matches:
- Rituxan
Ingredient matches for Rituxan
Rituximab
Rituximab is reported as an ingredient of Rituxan in the following countries:
- Canada
- Japan
- United States
International Drug Name Search
No comments:
Post a Comment